Bayer Hopeful Of Sweet Success With KaNDy Buy

Gets Hold Of Late-Stage Non-Hormonal Menopause Drug

 
• By Kevin Grogan
KaNDy_Therapeutics
In demand: CEO Mary Kerr (c) and colleagues • Source: KaNDy Therapeutics

More from Deals

More from Business